Document is current
Any future updates will be listed below
-
Authors
Cagno, Valeria
Medaglia, Chiara
Cerny, Andreas
Cerny, Thomas
Zwygart, Arnaud Charles-Antoine
Cerny, Erich
Tapparel, Caroline
-
Funding
Funding for this research was provided by:
Fondation des HUG
Carigest Foundation
- License Information
-
More Information
Article History
Received: 23 December 2020
Accepted: 8 June 2021
First Online: 12 July 2021
Competing interests
: E.C., T.C., A.C., C.T. have a Swiss patent application pending covering the use of Methylene blue as an anti-viral drug for SARS-CoV-2. The other authors declare no conflict of interest.
